Vanda Pharma Historical PE Ratio image   This VNDA PE ratio history page last updated 5/5/2023
Vanda Pharma Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2023
5/3/2023
6.390.060.2426.6
Q4 2022
2/8/2023
7.150.120.4814.9
Q3 2022
11/2/2022
10.310.060.2443.0
Q2 2022
8/3/2022
10.800.050.2054.0
Q1 2022
5/5/2022
9.80-0.11-0.44NA
Q4 2021
2/23/2022
13.070.120.4827.2
Q3 2021
11/3/2021
21.140.140.5637.8
Q2 2021
7/28/2021
19.530.170.6828.7
Q1 2021
5/5/2021
16.580.150.6027.6
Q4 2020
2/10/2021
15.410.150.6025.7
Q3 2020
10/28/2020
10.090.110.4422.9
Q2 2020
8/5/2020
11.020.160.6417.2
Q1 2020
5/6/2020
11.690.010.04292.2
Q4 2019
2/25/2020
11.470.080.3235.8
Q3 2019
11/6/2019
13.140.230.9214.3
Q2 2019
7/31/2019
12.450.281.1211.1
Q1 2019
5/1/2019
16.000.060.2466.7
Q4 2018
2/13/2019
18.420.261.0417.7
Q3 2018
11/7/2018
20.450.200.8025.6
Q2 2018
8/1/2018
20.650.140.5636.9
Q1 2018
5/2/2018
13.950.140.5624.9
Q4 2017
2/14/2018
15.850.030.12132.1
Q3 2017
11/7/2017
14.95-0.03-0.12NA
Q2 2017
8/2/2017
15.450.030.12128.8
Q1 2017
5/2/2017
14.85-0.11-0.44NA
Q4 2016
2/15/2017
14.500.080.3245.3
Q3 2016
11/2/2016
14.35-0.01-0.04NA
Q2 2016
7/27/2016
11.290.010.04282.2
Q1 2016
5/4/2016
8.32-0.17-0.68NA
Q4 2015
2/10/2016
7.84-0.23-0.92NA
Q3 2015
11/3/2015
10.66-0.22-0.88NA
Q2 2015
7/29/2015
11.14-0.01-0.04NA
Q1 2015
5/6/2015
9.31-0.24-0.96NA
Q4 2014
2/19/2015
11.31-0.36-1.44NA
Q3 2014
10/27/2014
11.04-0.04-0.16NA
Q2 2014
8/7/2014
12.82-0.64-2.56NA
Q1 2014
5/8/2014
10.14-0.79-3.16NA
Q4 2013
2/13/2014
13.40-0.23-0.92NA
Q3 2013
11/7/2013
5.84-0.17-0.68NA
Q2 2013
7/31/2013
11.67-0.11-0.44NA
Q1 2013
5/9/2013
5.06-0.15-0.60NA
Q4 2012
2/12/2013
3.97-0.23-0.92NA
Q3 2012
11/7/2012
3.32-0.19-0.76NA
Q2 2012
8/2/2012
4.06-0.28-1.12NA
Vanda Pharma PE History Chart
PeriodPriceGAAPTTMPE
Q1 2023
5/3/2023
6.390.060.2922.0
Q4 2022
2/8/2023
7.150.120.1259.6
Q3 2022
11/2/2022
10.310.060.1285.9
Q2 2022
8/3/2022
10.800.050.2054.0
Q1 2022
5/5/2022
9.80-0.110.3230.6
Q4 2021
2/23/2022
13.070.120.5822.5
Q3 2021
11/3/2021
21.140.140.6134.7
Q2 2021
7/28/2021
19.530.170.5833.7
Q1 2021
5/5/2021
16.580.150.5729.1
Q4 2020
2/10/2021
15.410.150.4335.8
Q3 2020
10/28/2020
10.090.110.3628.0
Q2 2020
8/5/2020
11.020.160.4823.0
Q1 2020
5/6/2020
11.690.010.6019.5
Q4 2019
2/25/2020
11.470.080.6517.6
Q3 2019
11/6/2019
13.140.230.8315.8
Q2 2019
7/31/2019
12.450.280.8015.6
Q1 2019
5/1/2019
16.000.060.6624.2
Q4 2018
2/13/2019
18.420.260.7424.9
Q3 2018
11/7/2018
20.450.200.5140.1
Q2 2018
8/1/2018
20.650.140.2873.7
Q1 2018
5/2/2018
13.950.140.1782.1
Q4 2017
2/14/2018
15.850.03-0.08NA
Q3 2017
11/7/2017
14.95-0.03-0.03NA
Q2 2017
8/2/2017
15.450.03-0.01NA
Q1 2017
5/2/2017
14.85-0.11-0.03NA
Q4 2016
2/15/2017
14.500.08-0.09NA
Q3 2016
11/2/2016
14.35-0.01-0.40NA
Q2 2016
7/27/2016
11.290.01-0.61NA
Q1 2016
5/4/2016
8.32-0.17-0.63NA
Q4 2015
2/10/2016
7.84-0.23-0.70NA
Q3 2015
11/3/2015
10.66-0.22-0.83NA
Q2 2015
7/29/2015
11.14-0.01-0.65NA
Q1 2015
5/6/2015
9.31-0.24-1.28NA
Q4 2014
2/19/2015
11.31-0.36-1.83NA
Q3 2014
10/27/2014
11.04-0.04-1.70NA
Q2 2014
8/7/2014
12.82-0.64-1.83NA
Q1 2014
5/8/2014
10.14-0.79-1.30NA
Q4 2013
2/13/2014
13.40-0.23-0.66NA
Q3 2013
11/7/2013
5.84-0.17-0.66NA
Q2 2013
7/31/2013
11.67-0.11-0.68NA
Q1 2013
5/9/2013
5.06-0.15-0.85NA
Q4 2012
2/12/2013
3.97-0.23NANA
Q3 2012
11/7/2012
3.32-0.19NANA
Q2 2012
8/2/2012
4.06-0.28NANA
Quotes delayed 20 minutes

Email EnvelopeFree VNDA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Vanda Pharma (VNDA) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

VOR PE Ratio History
VRAY PE Ratio History
VRCA PE Ratio History
VRDN PE Ratio History
VREX PE Ratio History
VRPX PE Ratio History
VRTX PE Ratio History
VSTM PE Ratio History
VTGN PE Ratio History
VTRS PE Ratio History
How should the VNDA historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Vanda Pharma. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this VNDA Historical PE Ratio page.

What is the average historical PE for VNDA based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The VNDA historical PE ratio using the annualized quarterly earnings method works out to 60.0.

What is the average historical PE for VNDA based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The VNDA historical PE ratio using the TTM earnings method works out to 36.8.

What is the average historical PE for VNDA based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The VNDA historical PE ratio using the annualized median TTM earnings method works out to 0.24.

On this page we presented the Vanda Pharma Historical PE Ratio information for Vanda Pharma' stock. The average VNDA historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 60.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average VNDA historical PE based on this TTM earnings result method is 36.8. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this VNDA historical PE result, against the recent PE: when this page was posted on 5/4/2023, the most recent closing price for VNDA had been 6.87, and the most recent quarterly earnings result, annualized, was 0.24. Meanwhile, the most recent TTM earnings summed to 0.29. From these numbers, we calculate the recent VNDA PE on 5/4/2023 based on annualized quarterly EPS was 28.6. Based on VNDA's history, that recent PE is low relative to the historical average, with the recent PE 52.3% lower than the historical average PE across our data set for Vanda Pharma. Looking at the recent VNDA PE on 5/4/2023 based on TTM EPS, we calculate the ratio at 23.7. Based on VNDA's history, that recent PE is low relative to the historical average, with the recent PE 35.6% lower than the average PE across our Vanda Pharma data set with TTM EPS used in the calculation at each period.

Another interesting VNDA historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for VNDA, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for VNDA, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.05, 0.06, 0.06, and 0.12. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.06 and 0.06 — which gives us the median of 0.06. Basically the way to think about this 0.06 number is this: for the trailing four earnings reports, 0.06 marks the "middle ground" number where VNDA has reported a value higher than 0.06 half the time, and has reported a value lower than 0.06 half the time. Annualizing that median value then gets us to 0.24/share, which we use as the denominator in our next PE calculation. With 6.87 as the numerator (as of 5/4/2023), the calculation is then 6.87 / 0.24 = 28.6 as the VNDA PE ratio as of 5/4/2023, based on that annualized median value we calculated.

For self directed investors doing their due diligence on VNDA or any other given stock, valuation analysis for VNDA can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Vanda Pharma PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for VNDA. Thanks for visiting, and the next time you need to research VNDA Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: WIZP Insider Buying, EMXC Options Chain, PCH Videos.

 

Vanda Pharma Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.